BIT 3.33% 3.1¢ biotron limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-54

  1. 994 Posts.
    lightbulb Created with Sketch. 316
    It's nice to feel warm and fuzzy about the prospects of any of Biotron's compounds working on cancer, especially if you know someone who has experienced cancer first hand. However the reality is any attempt to test a compound on cancer takes the company way back to square one and I really don't think MM & Co have the expertise, energy, know how and financial acumen to even attempt it. The company is under extreme financial stress to even keep the lights on let alone attempt a new endeavour like cancer testing.

    They literally have only 2-3 weeks of funding left and assuming they have prepared tax return in record time the processing of such claim takes 4 weeks. Talk about absolute $hit show. The CEO & Board must be overseeing one of the most insolvent companies on the ASX to be allowed to trade.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.